Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKinsey
McKesson
Merck
Mallinckrodt

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Ammonia n-13 - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for ammonia n-13 and what is the scope of freedom to operate?

Ammonia n-13 is the generic ingredient in one branded drug marketed by 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens Hosp, Cardinal Health 414, Central Radiopharm, Decatur, Essential Isotopes, Feinstein, Gen Hosp, Houston Cyclotron, Ionetix, Johns Hopkins Univ, Kreitchman Pet Ctr, Mcprf, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Spectron Mrc Llc, Ucla Biomedical, Ucsf Rodiopharm, Univ Tx Md Anderson, Wa Univ Sch Med, and Wi Medcl Cyclotron, and is included in twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for ammonia n-13. Twenty-three suppliers are listed for this compound.

Summary for ammonia n-13
Recent Clinical Trials for ammonia n-13

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
MallinckrodtPhase 3
Rubius TherapeuticsPhase 1
Zagazig UniversityN/A

See all ammonia n-13 clinical trials

Pharmacology for ammonia n-13
Synonyms for ammonia n-13
((sup 13)N)Ammonia
(13n)ammonia
[13N]Ammonia
[13N]NH3
34819-78-8
9OQO0E343Z
AC1L3OST
Ammonia (13N)
Ammonia N 13
Ammonia N 13 (TN)
Ammonia N 13 (USP)
Ammonia N 13 [USAN:USP]
Ammonia N 13 Injection
Ammonia N13
Ammonia-(sup 13)N
CHEBI:135980
CHEMBL1201189
D02915
DB09326
MOLI001000
MOLI001060
N-13 Ammonia
Nitrogen, isotope of mass 13, at.
QGZKDVFQNNGYKY-BJUDXGSMSA-N
UNII-9OQO0E343Z

US Patents and Regulatory Information for ammonia n-13

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gen Hosp AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 207025-001 Feb 3, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Ionetix AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 210524-001 Dec 21, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Brigham Womens Hosp AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 203783-001 Oct 30, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Midwest Medcl AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204457-001 Nov 18, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Baxter
Colorcon
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.